U.S. Research ELISA Markets

Frost & Sullivan, March 2008, Pages: 77

This Frost & Sullivan research service titled U.S. Research ELISA Markets provides revenue forecasts for the overall market. It provides in-depth analyses of market-wide and segment-specific drivers, restraints, and challenges, with the corresponding strategic recommendations. In this research, Frost & Sullivan's expert analysts thoroughly examine the following research ELISA markets: kits and development components.

Market Overview
Research ELISA’s Established Credentials Help it Weather Competition from Multiplex Proteomic Arrays

After a glorious 37-year run as a reliable and trusted technology for analyte quantitation, the research enzyme-linked immunosorbent assay (ELISA) technique has reached market maturity. It is drawing on its entrenched reputation for quality results and reproducibility to stave off the challenge mounted by newer multiplex proteomic array technologies. This new-age technology scores over the single-analyte quantitation technique of ELISA by offering high throughput capability and allowing researchers to measure multiple analytes simultaneously.

"While the increased use of multiplex proteomic array technologies has stalled the research ELISA market, new ELISA products remain profitable at the provider level," says the analyst of this research service. "Market participants are discovering that many laboratories still prefer the ELISA technique or continue using the technology for secondary validation after multiplexing." ELISA suppliers can also position their products as the ideal tools for researchers that do not need the advantages of multiplexing, focus only on a few analytes, and require high assay sensitivity. This strategy can help diffuse the threat of price instability, which is consequent to the commoditization of products for popular analytes.

With over 60 participants serving in the ELISA market, it is vital to focus new products on areas of research where multiplex arrays have not been developed. "Many providers are expected to slow the expansion of their ELISA portfolios or focus on niche markets and unique species to circumvent growing competition from proteomic arrays," observes the analyst. "ELISA providers must adapt their strategies to complement multiplex platforms rather than try to compete head-on." Increasingly, companies have opted to develop their own multiplex assay portfolios to take advantage of the new technology and expand customer options.

Technologies
The following technologies are covered in this research:

- Antibody pre-coated 96-well microplates, enzyme concentrate, diluents, wash buffer concentrate, substrate reagents, stop solution and an assay protocol
- Antibody pair, standard and conjugate (usually Streptavidin- horseradish peroxidase or alkaline phosphatase)
- Analyte (antigen, antibody, protein)

Market Sectors
Expert Frost & Sullivan analysts thoroughly examine the following market sectors in this research:

- Research ELISA kits
- Research ELISA development components

1. Executive Summary
- 1. Market Overview
- - 1. Introduction

2. Total Research ELISA Market
- 1. Market Overview
- - 1. Introduction
- - 2. Scope and Segmentation
- - 3. Research Methodology
- - 4. Market Engineering Measurements
- 2. Market Forecast and Competitive Analysis
- - 1. Revenue Forecasts
- - 2. Competitive Structure
- - 3. Competitive Metrics
- - 4. Market Share Analysis
- - 5. Mergers & Acquisitions
- 3. Industry Challenges and Strategic Recommendations
- - 1. Industry Challenges
- - 2. Strategic Recommendations

3. Research ELISA Kit Market
- 1. Market Overview
- - 1. Introduction
- - 2. Market Engineering Measurements
- 2. Market Drivers and Restraints
- - 1. Market Drivers
- - a. Entrenched Reputation in Research as a Trusted Technology Sustains Demand for ELISA Kits
- - b. Continued Biomarker Discovery Maintains Influx of Targets for ELISA Development
- - c. Multiplex Customer Base Utilizes ELISA Kits for Secondary Validation on Select Targets
- - 2. Market Restraints
- - a. Increasing Adoption of Multiplex Technologies Threatens Demand for Single Analyte Immunoassays
- - b. ELISA Providers’ Reallocation of Resources and Focus Toward Developing Multiplex Assays Stalls New ELISA Kit Introductions
- - c. Commoditization of ELISA Kits for Popular Analytes Jeopardizes Price Stability
- 3. Technology and Market Trends
- - 1. Technology Trends
- - 2. Market Trends
- 4. Market Forecasts and Competitive Analysis
- - 1. Revenue Forecasts
- - 2. Competitive Structure
- - 3. Market Share Analysis
- - 4. Product Analysis

4. Research ELISA Development Components Market
- 1. Market Overview
- - 1. Introduction
- - 2. Market Engineering Measurements
- 2. Market Drivers and Restraints
- - 1. Market Drivers
- - 2. Market Restraints
- 3. Technology and Market Trends
- - 1. Technology Trends
- - 2. Market Trends
- 4. Market Forecasts and Competitive Analysis
- - 1. Revenue Forecasts
- - 2. Competitive Structure
- - 3. Market Share Analysis
- - 4. Product Analysis

List of Figures

Chapter 2

- Total Research ELISA Market: Revenue Forecasts (U.S.), 2004-2014
- Total Research ELISA Market: Percent of Revenues by Market Segment (U.S.), 2007
- Total Research ELISA Market: Revenue Forecasts by Market Segment (U.S.), 2004-2014
- Total Research ELISA Market: Competitive Structure (U.S.), 2007
- Total Research ELISA Market: Competitive Metrics (U.S.), 2007
- Total Research ELISA Market: Company Market Share by Revenues (U.S.), 2007
- Total Research ELISA Market: Impact of Top Five Industry Challenges (U.S.), 2008-2014
- Total Research ELISA Market: Industry Challenges and Strategic Recommendations (U.S.), 2008-2014

Chapter 3

- Research ELISA Kit Market: Market Drivers Ranked in Order of Impact (U.S.), 2008-2014
- Research ELISA Kit Market: Market Restraints Ranked in Order of Impact (U.S.), 2008-2014
- Research ELISA Kit Market: Revenue Forecasts (U.S.), 2004-2014
- Research ELISA Kit Market: Competitive Structure (U.S.), 2007
- Research ELISA Kit Market: Company Market Share by Revenues (U.S.), 2007

Chapter 4

- Research ELISA Development Components Market: Market Drivers Ranked in Order of Impact (U.S.), 2008-2014
- Research ELISA Development Components Market: Market Restraints Ranked in Order of Impact (U.S.), 2008-2014
- Research ELISA Development Components Market: Revenue Forecasts (U.S.), 2004-2014
- Research ELISA Development Components Market: Competitive Structure (U.S.), 2007
- Research ELISA Development Components Market: Company Market Share by Revenues (U.S.), 2007
- Research ELISA Development Components Market: Database of Key Industry Participants by Product Type (U.S.), 2007

Customers who bought this item also bought

• Enzyme-Linked Immunosorbent Assay (ELISA). - Global Strategic Business Report
• Biomerica, Inc. (BMRA) - Product Pipeline Analysis
• OncoHealth Corporation - Product Pipeline Analysis
• Molecular Diagnostics - Technologies, Markets and Companies
• Autoimmune Technologies, LLC - Product Pipeline Analysis
• ZEUS Scientific, Inc. - Product Pipeline Analysis
• HIV-AIDS Testing Markets
• Immunoassay Systems - Global Business Strategic Report
• Biohit Oyj (BIOBV) - Product Pipeline Analysis
• Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. - Product Pipeline Analysis